EPx4 Raises Odds of Renal, Nerve, Hearing Harms - Quiz - MDSpire

EPx4 Raises Odds of Renal, Nerve, Hearing Harms

Multicenter outcomes study finds cisplatin dose drives toxicity differences between guideline-endorsed regimens, with kidney function decline predicting cardiovascular risk

  • By

  • Kerri Miller

  • February 25, 2026

  • 5 min

Share

Original Source(s)

EPx4 Raises Odds of Renal, Nerve, Hearing Harms

  • by Kerri Miller

  • February 25, 2026

Related Content

Synthetic Echo Motion May Aid ECG Risk Modeling

An ensemble electrocardiogram model classified derived diastolic dysfunction risk phenotypes and stratified heart failure–related death risk across external cohorts, according to findings presented at ASE 2026.

Echo AI: From Innovation to Adoption

Experts examined the evidence, practical applications, and barriers shaping AI integration in echocardiography.

PAHR: Prognostic Marker in Severe Aortic Stenosis?

Researchers evaluated whether a composite measure of heart rate and pressure could capture overall hemodynamic burden.